- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07072455
- Original Trial
Sensory Profile of People With High Intellectual Potential (HIP) (HPIsens)
Sensory Profile of People With High Intellectual Potential
This is a prospective observational psychology study on a non-clinical population, involving the use of questionnaires (non-interventional research).
This study involves the collection of data associated with High Intellectual Potential characteristics, sensory profile, and includes clinical measures such as anxiety anxiety, autistic traits and coping in High Intellectual Potential and control participants.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Aude Paquet, PhD in Psychology
- Phone Number: +33 5-55-43-11-27
- Email: aude.paquet@ch-esquirol-limoges.fr
Study Locations
-
-
Nouvelle-Aquitaine
-
Limoges, Nouvelle-Aquitaine, France, 87025
- Recruiting
- Esquirol Hospital Center
-
Contact:
- Alexandra Foucher, University degree
- Phone Number: +33 5-55-43-11-00
- Email: alexandra.foucher@ch-esquirol-limoges.fr
-
Principal Investigator:
- Aude Paquet, PhD in Psychology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Subjects with High Intellectual Potential will be recruited on a voluntary basis :
- in the offices of private psychologists, on the psychologist's recommendation or by posting in waiting rooms
- through communication on social networks Subjects control will be recruited on a voluntary basis from the personal and professional environment of the people involved in this study and through communication on social networks.
Description
Inclusion Criteria:
- High Intellectual Potential:
- Participants with a High Intellectual Potential : Cognitive assessment using the WAIS or WISC-V scale by a psychologist; Intelligence Quotient (IQ) ≥ 130, in the case of a homogeneous cognitive profile, or General Aptitude Index (GAI) > 130 [124-134], in the case of a heterogeneous cognitive profile
- Gender and Age: Male or female, aged 18 to 65
- Consent: Free, informed, and written consent (e-CRF)
- Control :
- Gender and Age: Male or female, aged 18 to 65
- Consent: Free, informed, and written consent (e-CRF)
Exclusion Criteria:
- High Intellectual Potential:
- History or declared psychiatric disorder (characterized depressive episode, personality disorder, addiction, eating disorder, bipolar disorder, obsessive-compulsive disorder)
- Neurodevelopmental disorders (autism spectrum disorder, attention deficit and hyperactivity disorder , developmental coordination disorder)
- Sensory disability
- Subjects under guardianship or curatorship
- Pregnant or breast-feeding women
- Control :
- Presence of High Intellectual Potential known
- Presence of intellectual development disorder
- History or declared psychiatric disorder (characterized depressive episode, personality disorder, addiction, eating disorder, bipolar disorder, obsessive-compulsive disorder)
- Neurodevelopmental disorders (autism spectrum disorder, attention deficit and hyperactivity disorder , developmental coordination disorder)
- Sensory disability
- Subjects under guardianship or curatorship
- Pregnant or breast-feeding women
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
High Intellectual Potential
Subjects with a High Intellectual Potential : Cognitive assessment using the Wechsler Adult Intelligence Scale (WAIS-III or WAIS-IV) scale or Wechsler Intelligence Scale for Children (WISC-VI or WISC-V) scale by a psychologist. Intelligence Quotient (IQ) ≥ 130, in the case of a homogeneous cognitive profile, or General Aptitude Index (GAI) ≥ 130 [124-134], in the case of a heterogeneous cognitive profile |
This observational study consists of data collection using a structured questionnaire based on an e-CRF, distributed by e-mail. Four questionnaires were administered : the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS) and the State-Trait Anxiety Inventory (STAI-Y). Socio-demographic and treatments were collected.
For participants with High Intellectual Potential, the total Intelligence Quotient (IQ) or General Ability Index (GAI), along with the index scores from the Wechsler scales (Verbal Comprehension Index, Perceptual Reasoning Index, Working Memory Index, and Processing Speed Index), will be extracted from the cognitive assessment previously completed by the participant prior to study enrollment.
|
|
Control
Subjects whitout High Intellectual Potential
|
This observational study consists of data collection using a structured questionnaire based on an e-CRF, distributed by e-mail. Four questionnaires were administered : the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS) and the State-Trait Anxiety Inventory (STAI-Y). Socio-demographic and treatments were collected. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensory profile from the Adolescent and Adult Sensory Profile according to each group.
Time Frame: At enrollment
|
Sensory profile scores is obtained using the self-report questionnaire Adolescent and Adult Sensory Profile (AASP) after the participant has been included in the study.
Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance are collected.
For each subscore, the minimum and maximum values range from 15 to 75.
A high score indicates high sensory sensitivity.
|
At enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of the frequency of autistic traits for each group
Time Frame: At enrollment
|
The frequency of autistic traits will be obtained using the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr) during an individual interview after the participant has been included in the study.
The minimum and maximum values range from 0 to 240.
The generally accepted threshold for significant autistic traits is 70.
A high score indicate high autistic traits.
|
At enrollment
|
|
Sensory profile from the Adolescent and Adult Sensory Profile according to the cognitive profile of the High Intellectual Potential group.
Time Frame: At enrollment
|
Sensory profile scores will be obtained using the Adolescent and Adult Sensory Profile (AASP) scale during an individual interview after the participant has been included in the study.
Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance will be collected.
For each subscore, the minimum and maximum values range from 15 to 75.
A high score indicates high sensory sensitivity.
|
At enrollment
|
|
Scores for anxiety from the State and Trait Anxiety Inventory according to each group
Time Frame: At enrollment
|
Anxiety scores will be obtained using the State and Trait Anxiety Inventory (STAI-Y) scale during an individual interview after the participant has been included in the study.
Subscores for State Anxiety and Trait Anxiety will be collected.
For each subscore, the minimum and maximum values range from 20 to 80.
A high score indicates high anxiety
|
At enrollment
|
|
Scores for task coping drawn from the Coping Inventory for Stressful Situations according to each group
Time Frame: At enrollment
|
Coping scores will be obtained using the Coping Inventory for Stressful Situations (CISS) scale during an individual interview after the participant has been included in the study.
The task-oriented coping subscore, emotion subscore, avoidance subscore, distraction subscore, and social diversion subscore will be collected.
The minimum and maximum values range from 16 to 90.
A high score indicates high oriented coping.
|
At enrollment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2024-A02488-39
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Intellectual Potential
-
University Hospital, BrestCompletedChildren | High Intellectual PotentialFrance
-
Hospices Civils de LyonCompletedSleep Apnea | Narcolepsy | Healthy Subject | Temporo-central Epilepsy | High Intellectual PotentialFrance
-
Midnight Pharma, LLCCompletedAbuse Potential Study
-
Ain Shams UniversityCompletedSevoflurane | Dexmedetomidine | Spine Surgery | Propofol | Fentanyl | Motor Evoked Potential | Somatosensory Evoked PotentialEgypt
-
UNION therapeuticsCompletedIrritation Potential of Topic AgentUnited States
-
Arbor Pharmaceuticals, Inc.CompletedAbuse PotentialUnited States
-
Viatris Specialty LLCCompletedAbuse PotentialUnited States
-
Viatris Specialty LLCCompletedAbuse PotentialUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedA Potential Infectious Respiratory Clinical Syndrome | Potential Clinical Urinary Infectious Syndrome | A Potential Clinical Abdominal Infection SyndromeFrance
-
Samsung Medical CenterCompletedBrain Surgery With Motor Evoked Potential Monitoring | Spine Surgery With Motor Evoked Potential MonitoringKorea, Republic of
Clinical Trials on Scales
-
Centre Hospitalier EsquirolNot yet recruitingAnorexia Nervosa | Hyperphagia | Eating Disorders | Boulimia NervosaFrance
-
Gazi UniversityCompleted
-
University Hospital, LilleCompletedSystemic SclerosisFrance
-
University Hospital, BordeauxActive, not recruiting
-
Hacettepe UniversityCompletedVoice | Voice Disorders in ChildrenTurkey
-
Recep Tayyip Erdogan University Training and Research...CompletedDental Anxiety | Behavior, Child | Preference, PatientTurkey
-
Hasan Kalyoncu UniversityCompletedSleep Disturbance | Headache | Bruxism, Sleep | Myofascial Temporomandibular Disorder | Jaw SpasmTurkey
-
Hospices Civils de LyonCompleted
-
Centre Hospitalier EsquirolCompleted
-
IRCCS San Camillo, Venezia, ItalyActive, not recruitingNeurologic Manifestations | Anxiety | Rehabilitation | Nurse-Patient Relations | Psychological | Mood Depressed | Coping Strategies